Diagnosing SAPHO syndrome can feel like solving a puzzle. This rare condition, which affects bones, joints, and skin in various combinations, often requires careful evaluation using a mix of clinical examinations, imaging studies, and sometimes tissue samples to confirm the presence of inflammation and rule out other similar diseases.

Introduction: When Should You Seek Diagnosis?

Anyone experiencing persistent bone or joint pain accompanied by unusual skin changes should consider seeking medical evaluation. SAPHO syndrome, which stands for synovitis (joint inflammation), acne, pustulosis (pus-filled blisters), hyperostosis (excessive bone growth), and osteitis (bone inflammation), typically appears in people between their teenage years and late adulthood, with most cases diagnosed when patients are between 30 and 40 years old.^[2]

The decision to undergo diagnostics often comes after months of unexplained discomfort. Because SAPHO syndrome develops gradually in most cases, many people initially dismiss their symptoms as ordinary aches and pains. The onset of bone and joint pain, stiffness, and swelling is usually slow and insidious rather than sudden.^[2] When these symptoms persist or worsen, particularly when combined with severe acne, thick yellow blisters on the palms and soles, or other skin changes, medical attention becomes essential.

Individuals who notice pain and swelling in the chest wall area, particularly around the breastbone and collarbones, should be especially attentive. In adults, inflammation most commonly affects the anterior chest wall, though it can also involve the spine, jaw, and hip bones. In younger patients, the pattern resembles chronic nonbacterial osteomyelitis, affecting long bones like those in the legs, as well as the clavicle and spine.^[2]

Rheumatic pain combined with pustular skin disease should prompt a visit to a healthcare professional, particularly a rheumatologist who specializes in inflammatory joint conditions.^[4] People experiencing severe pain that limits mobility, such as difficulty sitting upright or bearing weight, require urgent evaluation, as these symptoms can significantly impact quality of life and daily functioning.^[5]

Classic Diagnostic Methods

Diagnosing SAPHO syndrome requires a thoughtful combination of approaches because there is no single test that can definitively confirm the condition. Doctors typically begin by suspecting the syndrome based on clinical examination, which means carefully reviewing symptoms and conducting a physical assessment of affected areas.^[2]

Imaging Studies

Imaging procedures form the cornerstone of SAPHO syndrome diagnosis. These tests must confirm the diagnosis by showing a combination of bone changes that are characteristic of the condition. X-rays, computed tomography (CT) scans, and magnetic resonance imaging (MRI) are the primary imaging tools doctors use to visualize what is happening inside the bones and joints.^[2]

MRI scans are particularly valuable because they can reveal inflammation of the bone marrow or joints at characteristic sites such as the collarbone, breastbone, pelvis, heel, and lower jaw.^[4] These scans show a specific pattern of changes including osteolysis (breakdown of bone tissue) and osteosclerosis (abnormal hardening of bone) with secondary hyperostosis. Additionally, MRI can detect bone marrow swelling, inflammation of the inner and outer bone surfaces, muscle inflammation near the affected bone, and arthritis in nearby joints.^[2]

Different parts of the body show distinct patterns on imaging. In the anterior chest wall, which is affected in between 65 and 90 percent of patients, imaging typically reveals hyperostosis, hardening of bone tissue, and bone enlargement, especially involving the joint where the collarbone meets the breastbone. These changes often include a soft tissue component, meaning swelling extends beyond just the bone itself.^[3]

When the spine is involved, which occurs in about one-third of patients, imaging usually focuses on the thoracic spine (middle back area). The four main presentations doctors look for include inflammation affecting the disc space between vertebrae, areas of abnormal bone density, bone formation alongside the spine, and involvement of the sacroiliac joints that connect the spine to the pelvis.^[3]

In long bones, which are affected in approximately 30 percent of patients, changes usually appear in the area between the middle shaft and the end of the bone. The distal femur (lower thighbone) and proximal tibia (upper shinbone) are the most common sites. The appearance on imaging resembles chronic bone infection, but without the specific features of bacterial infection such as a sequestrum (dead bone fragment) or abscess.^[3]

Bone Biopsy

In some cases, doctors may recommend a bone biopsy, which involves removing a small sample of bone tissue for examination under a microscope. This procedure can provide valuable information about the type of inflammation present. In early stages of SAPHO syndrome, bone biopsy typically reveals an infiltrate of neutrophils, which are white blood cells that fight infection. As the disease progresses, these neutrophils are gradually replaced by other immune cells called mononuclear cells, and hardening of the bone tissue becomes more apparent.^[2]

Bone biopsy also helps doctors look for signs of what they call sterile osteomyelitis, which means inflammation that looks like a bone infection but without actual bacteria causing it.^[4] Sometimes, slow-growing bacteria such as Propionibacterium acnes (now called Cutibacterium acnes) may be found in bone samples. This bacterium, known for its role in acne, could act as a triggering factor for SAPHO syndrome, though its exact role remains uncertain.^[2]

Skin Examination and Biopsy

A thorough skin examination is essential because dermatological involvement is a key feature of SAPHO syndrome. Skin manifestations can include severe acne, pustular blisters on the palms and soles (palmoplantar pustulosis), and pustular psoriasis. Interestingly, skin changes often begin one to two years before bone problems become apparent, though they can appear at the same time or even more than 20 years later.^[2]

When examined under a microscope after a skin biopsy, the skin lesions in SAPHO syndrome show collections of inflammatory cells known as neutrophilic pseudoabscesses. These are concentrations of neutrophils that look like small abscesses but are not caused by infection.^[4]

Joint Fluid Analysis

If there is swelling in a joint, doctors might perform arthrocentesis, which means inserting a needle into the joint to withdraw fluid for testing. In SAPHO syndrome, analysis of synovial fluid (the liquid inside joints) typically shows signs of inflammation, but cultures to test for bacteria are usually negative. This finding helps distinguish SAPHO syndrome from infectious arthritis, where bacteria would be present in the joint fluid.^[2]

Ruling Out Other Conditions

A critical part of diagnosing SAPHO syndrome involves distinguishing it from other conditions that can look similar. This process is called differential diagnosis. SAPHO syndrome is often confused with suppurative osteomyelitis, which is a bacterial bone infection that shares similar clinical and microscopic findings.^[5] The diagnosis becomes even more challenging when unusual body sites are involved or when there are no skin changes to provide clues.^[7]

Doctors must also consider and rule out infectious osteomyelitis or arthritis caused by bacteria, Langerhans cell histiocytosis (a rare disorder involving overproduction of certain immune cells), and bone tumors such as Ewing sarcoma and osteoblastoma.^[2] Each of these conditions requires different treatment approaches, making accurate diagnosis essential for proper care.

Diagnostics for Clinical Trial Qualification

When patients with SAPHO syndrome are considered for participation in clinical trials, they typically undergo more standardized and detailed diagnostic evaluations. The purpose is to ensure that participants truly have the condition being studied and to establish baseline measurements that can be compared throughout the trial.

While specific clinical trial criteria for SAPHO syndrome are not extensively detailed in available research literature, the general diagnostic criteria used to define the condition serve as the foundation for trial enrollment. The original criteria proposed in 1987 included arthritis or bone inflammation linked to acne, pustular psoriasis, or palmoplantar pustulosis, or the presence of sterile bone inflammation affecting the spine or chest wall.^[16]

Clinical trials testing treatments for SAPHO syndrome would likely require participants to undergo comprehensive imaging studies to document the extent and location of bone and joint involvement. MRI scans would be particularly important to establish baseline measurements of inflammation that could be reassessed after treatment to determine whether the intervention is effective.

Blood tests to measure general markers of inflammation might also be part of trial enrollment criteria, though SAPHO syndrome does not have a specific blood test that can diagnose it. Documenting skin manifestations through physical examination and potentially photography would help track changes in dermatological symptoms over the course of a trial.

Because SAPHO syndrome can be confused with other inflammatory conditions, trial protocols would need to clearly specify how other conditions are ruled out. This might involve requiring negative cultures for bacteria in bone or joint fluid samples, specific imaging findings that match SAPHO syndrome patterns, and documentation of the characteristic combination of skin and musculoskeletal symptoms.

Patient-reported outcome measures would also be important in trials, with participants tracking pain levels, stiffness, mobility limitations, and the impact of the condition on daily activities. These subjective measures complement the objective findings from imaging and physical examination to provide a complete picture of disease severity and treatment response.